EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 13-Dec-2025 18:11 ET (13-Dec-2025 23:11 GMT/UTC)

Moffitt studies uncover complementary strategies to overcome resistance to KRAS G12Cinhibitors in lung cancer

H. Lee Moffitt Cancer Center & Research Institute
Peer-Reviewed Publication

Two companion studies published in Cancer Research from scientists at Moffitt Cancer Center identify distinct but complementary approaches to overcoming drug resistance in KRAS G12C–mutant non-small cell lung cancer.

Journal: Cancer Research
Funder: NIH/National Cancer Institute, NIH/National Cancer Institute, Bankhead-Coley Foundation

Mount Sinai Tisch Cancer Center debuts real-time data integration tool to make research faster and more accurate

The Mount Sinai Hospital / Mount Sinai School of Medicine
Business Announcement

The Mount Sinai Tisch Cancer Center has become one of the first elite research institutions in the United States to automate the transfer of clinical data from its electronic health record system into clinical trial platforms, helping doctors and researchers share information faster and more accurately during cancer clinical trials.

MD Anderson shares latest research breakthroughs

University of Texas M. D. Anderson Cancer Center
Peer-Reviewed Publication

Researchers characterize distinct immune environments in lymphoma, providing a new framework to engage the immune system in treating the disease

Study finds U.S. adults have widespread misperceptions of the cancer risks of alcohol

Scientists discover new target for pain hypersensitivity

Early clinical studies show encouraging results in kidney and prostate cancer

Rare vulvar cyst case report sheds light on diagnostic challenges

Impact Journals LLC
Peer-Reviewed Publication

BUFFALO, NY — October 30, 2025 — A new case report was published in Volume 12 of Oncoscience on October 9, 2025, titled “Vulvar mucinous cyst mimicking common lesions with concurrent multiple bartholin cysts in a reproductive-age woman: A rare case report and review of literature.”

Journal: Oncoscience

Consistent adherence to physical activity guidelines and digestive system cancer risk and mortality

JAMA Network
Peer-Reviewed Publication

The findings of this study suggest that maintaining a moderate level of physical activity of approximately 17 metabolic equivalent task-hours/week (i.e., 5 hours of brisk walking or 2 hours of running each week) over 3 decades was sufficient to achieve optimal benefit in reducing digestive system cancer risk.

Journal: JAMA Oncology

Beliefs about the effect of alcohol use on cancer risk in the us adult population

JAMA Network
Peer-Reviewed Publication

The findings of this study highlight the persistence of misbeliefs and knowledge gaps about the link between alcohol and cancer among U.S. adults, which may contribute to the continuous increase in alcohol consumption. Individuals who drink alcohol were more likely to believe that alcohol consumption has no effect on cancer risk, which is alarming, given the growing burden of alcohol-related cancers in the U.S.

Journal: JAMA Oncology

Americans have widespread misbeliefs about the cancer risks of alcohol, study finds

University of Texas M. D. Anderson Cancer Center
Peer-Reviewed Publication

Despite clear evidence linking alcohol use to increased cancer risks, public awareness of this connection remains low in the U.S., according to new research from The University of Texas MD Anderson Cancer Center. Researchers found that more than half of American adults (52.9%) did not know alcohol affects cancer risk.

Journal: JAMA Oncology

Comprehensive molecular profiling of renal medullary carcinoma identifies TROP2 as a promising therapeutic target

University of Texas M. D. Anderson Cancer Center
Peer-Reviewed Publication

Researchers at The University of Texas MD Anderson Cancer Center, in collaboration with BostonGene, conducted the largest and most comprehensive molecular analysis of renal medullary carcinoma (RMC), a rare and aggressive form of kidney cancer, leading to the identification of TROP2 as a promising therapeutic target.

Journal: Cancer Cell

Breast cancer risk varies between different hormonal contraceptives

Uppsala University
Peer-Reviewed Publication

Some common hormonal contraceptives are linked to a slightly higher risk of breast cancer than others. This is shown by a new Swedish study from Uppsala University, in which researchers followed more than two million women and teenage girls in Sweden to identify how different hormonal contraceptives affect the risk of breast cancer.

Journal: JAMA Oncology

Safeguarding fertility: pioneering study investigates key hormone for women with cancer choosing fertility preservation

University of Illinois Urbana-Champaign Cancer Center at Illinois
Peer-Reviewed Publication

Newly diagnosed female cancer patients of reproductive age have a very short window for storing their eggs and embryos before starting cancer treatment. This is a process known as fertility preservation (FP), which protects patients’ ability to have children in the future after completing cancer treatment. Currently, scientists cannot predict which women will be successful in achieving a pregnancy or a healthy live birth after completing chemotherapy and undergoing FP. In a recent study, researchers identified Anti-Mullerian Hormone (AMH) levels as a prognostic indicator for success rates in fertility treatments.

Journal: Frontiers in Oncology

50
51
52
53
54